199 related articles for article (PubMed ID: 15721982)
21. Immunization with vesicular stomatitis virus nucleocapsid protein induces autoantibodies to the 60 kD Ro ribonucleoprotein particle.
Huang SC; Pan Z; Kurien BT; James JA; Harley JB; Scofield RH
J Investig Med; 1995 Apr; 43(2):151-8. PubMed ID: 7735918
[TBL] [Abstract][Full Text] [Related]
22. Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.
Scofield RH; Racila DM; Gordon TP; Kurien BT; Sontheimer RD
J Rheumatol; 2000 Jan; 27(1):128-34. PubMed ID: 10648028
[TBL] [Abstract][Full Text] [Related]
23. Interaction of calcium and Ro60: increase of antigenicity.
Scofield RH; Kurien BT; Gross JK; Reed NB; Taylor AK; Dominguez N; Mehta P; Guthridge JM; Bachmann M
Mol Immunol; 2004 Jul; 41(8):809-16. PubMed ID: 15234560
[TBL] [Abstract][Full Text] [Related]
24. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.
Keech CL; Gordon TP; McCluskey J
J Immunol; 1996 Oct; 157(8):3694-9. PubMed ID: 8871672
[TBL] [Abstract][Full Text] [Related]
25. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE.
Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
Dis Markers; 2012; 33(1):19-34. PubMed ID: 22710866
[TBL] [Abstract][Full Text] [Related]
26. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
[TBL] [Abstract][Full Text] [Related]
27. Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.
Kurien BT; Porter A; Dorri Y; Iqbal S; D'Souza A; Singh A; Asfa S; Cartellieri M; Mathias K; Matsumoto H; Bachmann M; Hensley K; Scofield RH
Free Radic Biol Med; 2011 May; 50(10):1222-33. PubMed ID: 20946951
[TBL] [Abstract][Full Text] [Related]
28. Autoepitopes of the 52-kd SS-A/Ro molecule.
Kato T; Sasakawa H; Suzuki S; Shirako M; Tashiro F; Nishioka K; Yamamoto K
Arthritis Rheum; 1995 Jul; 38(7):990-8. PubMed ID: 7541994
[TBL] [Abstract][Full Text] [Related]
29. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies.
Alzolibani AA; Al Robaee AA; Al-Shobaili HA; Rasheed Z
Cell Immunol; 2013; 284(1-2):154-62. PubMed ID: 23973878
[TBL] [Abstract][Full Text] [Related]
30. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
[TBL] [Abstract][Full Text] [Related]
31. Disparate locations of the 52- and 60-kDa Ro/SS-A antigens in cultured human keratinocytes.
Yell JA; Wang L; Yin H; McCauliffe DP
J Invest Dermatol; 1996 Oct; 107(4):622-6. PubMed ID: 8823371
[TBL] [Abstract][Full Text] [Related]
32. Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response.
Wang G; Li H; Firoze Khan M
Free Radic Res; 2012 Dec; 46(12):1472-81. PubMed ID: 22950782
[TBL] [Abstract][Full Text] [Related]
33. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.
Terzoglou AG; Routsias JG; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Oct; 146(1):60-5. PubMed ID: 16968399
[TBL] [Abstract][Full Text] [Related]
34. The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure.
Wolin SL; Reinisch KM
Autoimmun Rev; 2006 Jul; 5(6):367-72. PubMed ID: 16890888
[TBL] [Abstract][Full Text] [Related]
35. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
[TBL] [Abstract][Full Text] [Related]
36. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus.
Elkon KB; Culhane L
J Immunol; 1984 May; 132(5):2350-6. PubMed ID: 6715882
[TBL] [Abstract][Full Text] [Related]
37. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A).
Topfer F; Gordon T; McCluskey J
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):875-9. PubMed ID: 7846070
[TBL] [Abstract][Full Text] [Related]
38. Specificity of autoantibodies for recombinant 60-kd and 52-kd Ro autoantigens.
St Clair EW; Burch JA; Saitta M
Arthritis Rheum; 1994 Sep; 37(9):1373-9. PubMed ID: 7945502
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune response to the Ro/SSA particle is directed to the human antigen.
Reichlin M; Rader M; Harley JB
Clin Exp Immunol; 1989 Jun; 76(3):373-7. PubMed ID: 2473859
[TBL] [Abstract][Full Text] [Related]
40. Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies.
Campos-Pinto I; Méndez L; Schouten J; Wilkins J; Fedorova M; Pitt AR; Davis P; Spickett CM
Free Radic Biol Med; 2019 Nov; 144():234-244. PubMed ID: 31075498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
